Literature DB >> 19833856

Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis.

Animesh Pardanani, Ayalew Tefferi, Mark R Litzow, Clive Zent, William J Hogan, Rebecca F McClure, David Viswanatha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19833856     DOI： 10.1182/blood-2009-07-234666

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.

Authors:  Jaehyeon Lee; Dal Sik Kim; Hye Soo Lee; Sam Im Choi; Yong Gon Cho
Journal:  Ann Lab Med       Date:  2017-01       Impact factor: 3.464

2.  Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases.

Authors:  Maymona G Abdelmagid; Mark R Litzow; Kristen B McCullough; Naseema Gangat; Animesh Pardanani; Hemant S Murthy; James M Foran; Rhett P Ketterling; David Viswanatha; Kebede H Begna; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2022-07-06       Impact factor: 9.812

3.  Extramedullary blast crisis as initial presentation in chronic myeloid leukemia with the e1a2 BCR-ABL1 transcript: A case report.

Authors:  D I Ai; Wei Liu; Gary Lu; Keyur Pravinchandra Patel; Z I Chen
Journal:  Mol Clin Oncol       Date:  2015-09-09

4.  Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Authors:  Shady Adnan-Awad; Daehong Kim; Helena Hohtari; Komal Kumar Javarappa; Tania Brandstoetter; Isabella Mayer; Swapnil Potdar; Caroline A Heckman; Soili Kytölä; Kimmo Porkka; Eszter Doma; Veronika Sexl; Matti Kankainen; Satu Mustjoki
Journal:  Leukemia       Date:  2020-11-09       Impact factor: 11.528

5.  Childhood chronic myeloid leukemia with monocytosis.

Authors:  Nidhi Gupta; Ritu Gupta; Surender Kumar Sharawat; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2010-09-30       Impact factor: 5.319

6.  A case of chronic myeloid leukemia with the m-bcr (p190) molecular rearrangement identified during treatment.

Authors:  Mariana Beatriz Asinari; Maximiliano Zeballos; Sturich Alicia; Brenda Nidia Ricchi; Ana Lisa Basquiera
Journal:  Rev Bras Hematol Hemoter       Date:  2014-11-26

7.  Chronic Myeloid Leukemia With P190 BCR-ABL Translocation and Persistent Moderate Monocytosis: A Case Report.

Authors:  Arianna Gatti; Alessandra Movilia; Lucia Roncoroni; Annalisa Citro; Sara Marinoni; Bruno Brando
Journal:  J Hematol (Brossard)       Date:  2018-09-01

8.  High incidence of minor and micro breakpoints in Chronic Myeloid Leukaemia with additional cytogenetic abnormalities at diagnosis - the Western Australian series.

Authors:  Emily Leung; Rebecca de Kraa; Alison Louw; Julian P Cooney
Journal:  Leuk Res Rep       Date:  2022-08-13

9.  Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era.

Authors:  Ting Shi; Li Chen; Mixue Xie; Wei Yuan; Yungui Wang; Xin Huang; Wanzhuo Xie; Haitao Meng; Yinjun Lou; Wenjuan Yu; Hongyan Tong; Xiujin Ye; Jinyan Huang; Jie Jin; Honghu Zhu
Journal:  Exp Hematol Oncol       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.